MISSISSAUGA, ON--(Marketwired - February 05, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), dedicated to the early detection of skin cancer, gave an update on recent business developments today, noting that late in 2014, its European pharmacy-focused channel partner commenced a pilot with a pharmacy chain in Sweden. In addition, MedX has signed an exclusive distribution agreement with one of Australia's and New Zealand's leading providers of medical, surgical and healthcare products to all sectors of these healthcare markets. "We are very pleased to be able to expand the distribution of our technology working with our...
↧
